(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 4028.00 | 3804.00 | 5.89 | 4028.00 | 3804.00 | 5.89 | 17126.00 | 18598.00 | -7.91 |
| Other Income | 18.00 | 10.00 | 80.00 | 18.00 | 10.00 | 80.00 | 123.00 | 50.00 | 146.00 |
| PBIDT | 387.00 | 258.00 | 50.00 | 387.00 | 258.00 | 50.00 | 2328.00 | 3335.00 | -30.19 |
| Interest | 149.00 | 171.00 | -12.87 | 149.00 | 171.00 | -12.87 | 621.00 | 752.00 | -17.42 |
| PBDT | 327.00 | 87.00 | 275.86 | 327.00 | 87.00 | 275.86 | 856.00 | 2583.00 | -66.86 |
| Depreciation | 427.00 | 394.00 | 8.38 | 427.00 | 394.00 | 8.38 | 1638.00 | 1344.00 | 21.88 |
| PBT | -100.00 | -307.00 | -67.43 | -100.00 | -307.00 | -67.43 | -782.00 | 1239.00 | -163.12 |
| TAX | -25.00 | -80.00 | -68.75 | -25.00 | -80.00 | -68.75 | -295.00 | 330.00 | -189.39 |
| Deferred Tax | -25.00 | -80.00 | -68.75 | -25.00 | -80.00 | -68.75 | -275.00 | 30.00 | -1016.67 |
| PAT | -75.00 | -227.00 | -66.96 | -75.00 | -227.00 | -66.96 | -487.00 | 909.00 | -153.58 |
| Equity | 247.00 | 247.00 | 0.00 | 247.00 | 247.00 | 0.00 | 247.00 | 247.00 | 0.00 |
| PBIDTM(%) | 9.61 | 6.78 | 41.66 | 9.61 | 6.78 | 41.66 | 13.59 | 17.93 | -24.19 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1944.85 |
| Dr. Reddys Labs. | 1163.40 |
| Cipla | 1465.60 |
| Lupin | 2400.90 |
| Zydus Lifesciences | 1102.35 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: